Companies: 10,795·Total market cap: $144.5T
Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNNNASDAQHealthcare● Active
$17.22
$-5.77(-25.10%)
Market Cap$755806464
P/E Ratio
52W High$55.65
52W Low$7.92
Overview

Anbio Biotechnology Class A Ordinary Shares (NNNN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · NNNN · as of Jun 8, 2026

Key Statistics

EPS (TTM)$0.22nnnn eps ttm · nnnn earnings per shareEarnings history
PE Ratio (TTM)76.8×nnnn pe ratio ttm · nnnn price to earningsPE Ratio deep dive
Revenue (TTM)$18.6Mnnnn revenue ttm · nnnn annual revenueFull revenue history
Dividend YieldNo Dividenddoes nnnn pay dividends · nnnn dividend yieldDividend history
Shares Outstanding43.9Mnnnn shares outstanding · nnnn floatShares outstanding history
Next EarningsTBAnnnn earnings date · nnnn next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$9.8M▲ +19.22% YoY
202320242025
anbio biotechnology class a ordinary shares revenue · nnnn revenue 2025
FY 2025Net Income$7.2M▲ +204.56% YoY
202320242025
anbio biotechnology class a ordinary shares net income · nnnn profit 2025
FY 2025EPS$0.16▲ +185.71% YoY
202320242025
nnnn eps · anbio biotechnology class a ordinary shares earnings per share 2025
TTM:Revenue: $18.6MNet Income: $9.7MEPS: $0.22View income statement →

Stock Performance

Full History
1D-25.10%
1W-44.42%
1M-33.36%
3M-24.77%
YTD-42.73%
1Y+104.51%
5Y+198.44%

About Anbio Biotechnology Class A Ordinary Shares

CEOMichael Lau
IPO DateFeb 19, 2025
Employees27
CountryDE
Websiteanbio.com

Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers reg…

what is anbio biotechnology class a ordinary shares · nnnn stock overview · anbio biotechnology class a ordinary shares company profile · who is anbio biotechnology class a ordinary shares ceo · nnnn NASDAQ · anbio biotechnology class a ordinary shares headquarters · anbio biotechnology class a ordinary shares business segments

About Stock Overview & Key Data

Anbio Biotechnology Class A Ordinary Shares (NNNN) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Feb 19, 2025. As of the latest trading session, NNNN stock price is $17.22, with a market capitalization of $755.8M. The stock has returned +104.51% over the past 12 months and -42.73% year-to-date.

In fiscal year 2025, Anbio Biotechnology Class A Ordinary Shares reported revenue of $9.8M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Anbio Biotechnology Class A Ordinary Shares (NNNN) stock price is $17.22. The stock is traded on NASDAQ under the ticker symbol NNNN. The 52-week range is $7.92 – $55.65.

NNNN stock priceNNNN quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice